News Quantified

ASRT – assertio holdings, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements [Yahoo! Finance]

Assertio regains Nasdaq compliance after bid price recovery [Seeking Alpha]

Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story [Yahoo! Finance]

Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

14.9%

BEAT

4.1%

BEAT

-1.1%

BEAT

-7.5%

BEAT

Form 8-K Assertio Holdings, Inc. For: Jan 12

Form 8-K Assertio Holdings, Inc. For: Dec 19

Form 8-K Assertio Holdings, Inc. For: Nov 17

Form 4 Assertio Holdings, Inc. For: Nov 13 Filed by: Reisenauer Mark L

Form 4 Assertio Holdings, Inc. For: Nov 10 Filed by: Stark David Matthew

Top News Gainers

12/12 Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million 48.2%

2/6 Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million 46.2%

3/11 Assertio Therapeutics Announces Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes Due 2021 and 5.00% Senior Convertible Notes Due 2024 22.4%

12/13 Hedge Funds Are Crazy About Assertio Therapeutics, Inc. (ASRT) [Yahoo! Finance News] 15.7%

3/25 Form SC TO-I/A Assertio Therapeutics, Filed by: Assertio Therapeutics, Inc 14.9%

11/12 Form SC 13G Assertio Therapeutics, Filed by: D. E. SHAW & CO, L.P. 11.2%

8/20 Form 4 Assertio Therapeutics, For: Aug 19 Filed by: HIGGINS ARTHUR J 10.9%

2/19 Assertio Therapeutics Announces Repurchase of Approximately $188.0 Million of its Outstanding Convertible Debt 9.5%

4/24 Form 8-K Assertio Therapeutics, For: Apr 22 9.1%

10/5 How Does Assertio Therapeutics, Inc. (NASDAQ:ASRT) Affect Your Portfolio Volatility? [Yahoo! Finance News] 9.0%

Top News Decliners

8/9 Assertio Therapeutics, Inc (ASRT) Q2 2019 Earnings Call Transcript [The Motley Fool] -45.9%

3/9 Q4/2019 12/31/2019 EPS -0.140 ZacksConsensus -0.220 ActVsEst 0.080 - Beat -30.8%

10/21 Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin -24.9%

8/20 Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference -17.4%

10/30 Ceridian HCM Holding, BJ's Wholesale Club Holdings Set to Join S&P MidCap 400; Oceaneering International, Covetrus to Join S&P SmallCap 600 -15.0%

11/6 Assertio Therapeutics, Inc. 2019 Q3 - Results - Earnings Call Presentation [Seeking Alpha] -12.2%

3/2 Assertio Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results After the Close of Markets on Monday, March 9, 2020 -11.8%

1/13 Form 8-K Assertio Therapeutics, For: Jan 10 -9.4%

4/21 Form 425 Assertio Therapeutics, Filed by: Assertio Therapeutics, Inc -7.9%

5/9 Form 4 Assertio Therapeutics, For: May 09 Filed by: MCKEE WILLIAM -7.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day